Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2

Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2

Although not being the first viral pandemic to affect humankind, we are now for the first time faced with a pandemic caused by a coronavirus. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been responsible for the COVID-19 pandemic, which caused more than 4.5 million deaths wor...

Full description

Bibliographic Details
Main Authors: Renata Fioravanti Tarabini, Mauricio Menegatti Rigo, André Faustino Fonseca, Felipe Rubin, Rafael Bellé, Lydia E Kavraki, Tiago Coelho Ferreto, Dinler Amaral Antunes, Ana Paula Duarte de Souza
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
structural bioinformatics
BCG
vaccine
cross-reactivity
HLA
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.812176/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.812176/full

Similar Items